Mucinous differentiation in colon adenocarcinoma across different degrees of mucinous component: clinicopathological features, mismatch repair status, and survival trends


Ocak S., Atmış Ö., Mavili H. S., Dokuzlu Küçük E., Ayhan S.

38th European Congress of Pathology, Stockholm, İsveç, 12 - 16 Eylül 2026, cilt.489, ss.532, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Cilt numarası: 489
  • Basıldığı Şehir: Stockholm
  • Basıldığı Ülke: İsveç
  • Sayfa Sayıları: ss.532
  • Manisa Celal Bayar Üniversitesi Adresli: Evet

Özet

Background & Objectives: This study aimed to evaluate clinicopathological features, mismatch repair (MMR) status and survival outcomes of colon adenocarcinomas according to the presence and extent of mucinous differentiation. Methods: A total of 204 colon adenocarcinomas were retrospectively analysed, including 187 conventional adenocarcinomas and 17 mucinous adenocarcinomas. Tumours were categorised according to mucinous component as 0%, 1–49%, and ≥50%. Clinicopathological parameters, including extramural venous invasion (EMVI), intramural venous invasion (IMVI), lymphovascular invasion (LVI), perineural invasion (PNI), tumour location, MMR status and overall survival, were compared between groups. Results: Of the 204 tumours, 163 (79.9%) showed no mucinous component, 24 (11.8%) showed 1–49% mucinous component, and 17 (8.3%) showed ≥50% mucinous component; overall, 41 tumours (20.1%) showed mucinous differentiation. Mucinous differentiation was not significantly associated with sex, lymph node metastasis, tumour deposits, EMVI, IMVI, LVI, PNI, pT stage, pN stage, tumour grade, immune response pattern or serosal involvement. In contrast, significant associations were observed for MMR status and tumour location. Tumours with mucinous differentiation showed a higher dMMR rate than those without mucinous differentiation (26.8% vs 7.4%, p=0.001) and were more often right-sided (63.4% vs 35.4%, p=0.001). Across the three groups, the dMMR rate increased from 7.4% in tumours without mucinous component to 25.0% in those with 1–49% mucinous component and 29.4% in those with ≥50% mucinous component (p=0.002). Right-sided location was also more frequent in tumours with mucinous differentiation (p=0.004). In survival analysis, mucinous differentiation was associated with shorter overall survival, although not statistically significant (log-rank p=0.090). Conclusion: Mucinous differentiation was not associated with adverse histopathological features; this suggests that its value as a marker of aggressive tumour behaviour is limited. However, its strong association with dMMR and rightsided location, combined with the increased frequency of dMMR in higher mucinous categories, appears to indicate a distinct biological background rather than independent prognostic significance.